Junfei Cheng

438 total citations
12 papers, 361 citations indexed

About

Junfei Cheng is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Junfei Cheng has authored 12 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Oncology and 2 papers in Organic Chemistry. Recurrent topics in Junfei Cheng's work include Protein Degradation and Inhibitors (9 papers), Ubiquitin and proteasome pathways (8 papers) and Peptidase Inhibition and Analysis (3 papers). Junfei Cheng is often cited by papers focused on Protein Degradation and Inhibitors (9 papers), Ubiquitin and proteasome pathways (8 papers) and Peptidase Inhibition and Analysis (3 papers). Junfei Cheng collaborates with scholars based in China. Junfei Cheng's co-authors include Chunquan Sheng, Guoqiang Dong, Shipeng He, Ying Wu, Shanchao Wu, Yu Li, Xu Wang, Min Huang, Yahui Huang and Kun Fang and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry.

In The Last Decade

Junfei Cheng

12 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junfei Cheng China 8 298 125 68 61 26 12 361
Daniel Herp Germany 11 498 1.7× 216 1.7× 115 1.7× 72 1.2× 26 1.0× 13 574
Lijiao Wang China 10 157 0.5× 67 0.5× 97 1.4× 30 0.5× 17 0.7× 24 334
Julia M. Wagner Germany 6 413 1.4× 154 1.2× 69 1.0× 22 0.4× 74 2.8× 7 523
Yufeng Xiao United States 9 266 0.9× 117 0.9× 25 0.4× 20 0.3× 49 1.9× 15 343
Sören Swyter Germany 6 232 0.8× 93 0.7× 46 0.7× 68 1.1× 27 1.0× 8 313
Nina Reßing Germany 6 279 0.9× 126 1.0× 75 1.1× 8 0.1× 7 0.3× 8 300
Shawn Misialek United States 7 171 0.6× 67 0.5× 44 0.6× 7 0.1× 43 1.7× 13 266
Huaxiang Tong United States 13 296 1.0× 88 0.7× 52 0.8× 18 0.3× 16 0.6× 16 389
Laura Simons France 7 144 0.5× 59 0.5× 13 0.2× 25 0.4× 9 0.3× 11 279
Sen-Hao Xiao China 12 234 0.8× 35 0.3× 24 0.4× 47 0.8× 21 0.8× 14 298

Countries citing papers authored by Junfei Cheng

Since Specialization
Citations

This map shows the geographic impact of Junfei Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junfei Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junfei Cheng more than expected).

Fields of papers citing papers by Junfei Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junfei Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junfei Cheng. The network helps show where Junfei Cheng may publish in the future.

Co-authorship network of co-authors of Junfei Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Junfei Cheng. A scholar is included among the top collaborators of Junfei Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junfei Cheng. Junfei Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Cheng, Junfei, Jing Zhang, Shipeng He, et al.. (2024). Photoswitchable PROTACs for Reversible and Spatiotemporal Regulation of NAMPT and NAD+. Angewandte Chemie International Edition. 63(12). e202315997–e202315997. 19 indexed citations
2.
Cheng, Junfei, Jing Zhang, Shipeng He, et al.. (2024). Photoswitchable PROTACs for Reversible and Spatiotemporal Regulation of NAMPT and NAD+. Angewandte Chemie. 136(12). 1 indexed citations
3.
Cheng, Junfei, Guoqiang Dong, Wei Wang, & Chunquan Sheng. (2024). Precise Modulation of Protein Degradation by Smart PROTACs. ChemBioChem. 26(1). e202400682–e202400682. 4 indexed citations
4.
Song, Yingqi, et al.. (2023). Hydrophobic tagging-induced degradation of NAMPT in leukemia cells. Chinese Chemical Letters. 35(9). 109392–109392. 3 indexed citations
5.
He, Shipeng, et al.. (2022). Hydrophobic Tagging-Induced Degradation of PDEδ in Colon Cancer Cells. ACS Medicinal Chemistry Letters. 13(2). 298–303. 15 indexed citations
6.
Cheng, Junfei, Shipeng He, Jun Xu, et al.. (2022). Making Protein Degradation Visible: Discovery of Theranostic PROTACs for Detecting and Degrading NAMPT. Journal of Medicinal Chemistry. 65(23). 15725–15737. 30 indexed citations
7.
Cheng, Junfei, Shipeng He, Yuxin Fang, et al.. (2022). Discovery of Highly Potent Nicotinamide Phosphoribosyltransferase Degraders for Efficient Treatment of Ovarian Cancer. Journal of Medicinal Chemistry. 66(1). 1048–1062. 23 indexed citations
8.
Dong, Guoqiang, Ying Wu, Junfei Cheng, et al.. (2022). Ispinesib as an Effective Warhead for the Design of Autophagosome-Tethering Chimeras: Discovery of Potent Degraders of Nicotinamide Phosphoribosyltransferase (NAMPT). Journal of Medicinal Chemistry. 65(11). 7619–7628. 54 indexed citations
9.
He, Shipeng, Guoqiang Dong, Junfei Cheng, Ying Wu, & Chunquan Sheng. (2022). Strategies for designing proteolysis targeting chimaeras (PROTACs). Medicinal Research Reviews. 42(3). 1280–1342. 82 indexed citations
10.
Cheng, Junfei, Yu Li, Xu Wang, Guoqiang Dong, & Chunquan Sheng. (2020). Discovery of Novel PDEδ Degraders for the Treatment of KRAS Mutant Colorectal Cancer. Journal of Medicinal Chemistry. 63(14). 7892–7905. 57 indexed citations
11.
Wang, Lei, Kun Fang, Junfei Cheng, et al.. (2019). Scaffold Hopping of Natural Product Evodiamine: Discovery of a Novel Antitumor Scaffold with Excellent Potency against Colon Cancer. Journal of Medicinal Chemistry. 63(2). 696–713. 66 indexed citations
12.
Li, Xiaokang, Yahui Huang, Junfei Cheng, et al.. (2018). Discovery of novel Syk/PDGFR-α/c-Kit inhibitors as multi-targeting drugs to treat rheumatoid arthritis. Bioorganic & Medicinal Chemistry. 26(15). 4375–4381. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026